BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8100289)

  • 1. Effects of oxygen on dyspnoea in hypoxaemic terminal-cancer patients.
    Bruera E; de Stoutz N; Velasco-Leiva A; Schoeller T; Hanson J
    Lancet; 1993 Jul; 342(8862):13-4. PubMed ID: 8100289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of oxygen and opioids in the palliation of dyspnoea in hypoxic and non-hypoxic palliative care patients: a prospective study.
    Clemens KE; Quednau I; Klaschik E
    Support Care Cancer; 2009 Apr; 17(4):367-77. PubMed ID: 18719948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, randomised, controlled Phase II trial of Heliox28 gas mixture in lung cancer patients with dyspnoea on exertion.
    Ahmedzai SH; Laude E; Robertson A; Troy G; Vora V
    Br J Cancer; 2004 Jan; 90(2):366-71. PubMed ID: 14735178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic benefit of supplemental oxygen in hypoxemic patients with terminal cancer: the use of the N of 1 randomized controlled trial.
    Bruera E; Schoeller T; MacEachern T
    J Pain Symptom Manage; 1992 Aug; 7(6):365-8. PubMed ID: 1517652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised trial of domiciliary, ambulatory oxygen in patients with COPD and dyspnoea but without resting hypoxaemia.
    Moore RP; Berlowitz DJ; Denehy L; Pretto JJ; Brazzale DJ; Sharpe K; Jackson B; McDonald CF
    Thorax; 2011 Jan; 66(1):32-7. PubMed ID: 20880870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxaemia.
    Garrod R; Paul EA; Wedzicha JA
    Thorax; 2000 Jul; 55(7):539-43. PubMed ID: 10856310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxygen therapy for dyspnoea in adults.
    Cranston JM; Crockett A; Currow D
    Cochrane Database Syst Rev; 2008 Jul; (3):CD004769. PubMed ID: 18646110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis.
    Uronis HE; Currow DC; McCrory DC; Samsa GP; Abernethy AP
    Br J Cancer; 2008 Jan; 98(2):294-9. PubMed ID: 18182991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease.
    Uronis H; McCrory DC; Samsa G; Currow D; Abernethy A
    Cochrane Database Syst Rev; 2011 Jun; (6):CD006429. PubMed ID: 21678356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial.
    Abernethy AP; McDonald CF; Frith PA; Clark K; Herndon JE; Marcello J; Young IH; Bull J; Wilcock A; Booth S; Wheeler JL; Tulsky JA; Crockett AJ; Currow DC
    Lancet; 2010 Sep; 376(9743):784-93. PubMed ID: 20816546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does oxygen help dyspnea in patients with cancer?
    Booth S; Kelly MJ; Cox NP; Adams L; Guz A
    Am J Respir Crit Care Med; 1996 May; 153(5):1515-8. PubMed ID: 8630595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxygen for end-of-life lung cancer care: managing dyspnea and hypoxemia.
    Tiep B; Carter R; Zachariah F; Williams AC; Horak D; Barnett M; Dunham R
    Expert Rev Respir Med; 2013 Oct; 7(5):479-90. PubMed ID: 24138692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, crossover trial of the effect of oxygen on dyspnea in patients with advanced cancer.
    Philip J; Gold M; Milner A; Di Iulio J; Miller B; Spruyt O
    J Pain Symptom Manage; 2006 Dec; 32(6):541-50. PubMed ID: 17157756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of supplemental oxygen versus air in cancer patients with dyspnea.
    Bruera E; Sweeney C; Willey J; Palmer JL; Strasser F; Morice RC; Pisters K
    Palliat Med; 2003 Dec; 17(8):659-63. PubMed ID: 14694916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supplemental oxygen improves exercise capacity in IPF patients with exertional desaturation.
    Arizono S; Furukawa T; Taniguchi H; Sakamoto K; Kimura T; Kataoka K; Ogawa T; Watanabe F; Kondoh Y
    Respirology; 2020 Nov; 25(11):1152-1159. PubMed ID: 32367694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Flow Oxygen and High-Flow Air for Dyspnea in Hospitalized Patients with Cancer: A Pilot Crossover Randomized Clinical Trial.
    Hui D; Hernandez F; Urbauer D; Thomas S; Lu Z; Elsayem A; Bruera E
    Oncologist; 2021 May; 26(5):e883-e892. PubMed ID: 33289276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of hyperoxia on resting pattern of ventilation and dyspnoea in COPD.
    Moore R; Berlowitz D; Pretto J; Brazzale D; Denehy L; Jackson B; McDonald C
    Respirology; 2009 May; 14(4):545-50. PubMed ID: 19383112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Symptomatic treatment of dyspnoea in patients receiving palliative care: nasal delivery of oxygen compared with opioid administration].
    Clemens KE; Klaschik E
    Dtsch Med Wochenschr; 2007 Sep; 132(38):1939-43. PubMed ID: 17853348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palliative use of non-invasive ventilation in end-of-life patients with solid tumours: a randomised feasibility trial.
    Nava S; Ferrer M; Esquinas A; Scala R; Groff P; Cosentini R; Guido D; Lin CH; Cuomo AM; Grassi M
    Lancet Oncol; 2013 Mar; 14(3):219-27. PubMed ID: 23406914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disabling dyspnoea in patients with advanced disease: lack of effect of nebulized morphine.
    Noseda A; Carpiaux JP; Markstein C; Meyvaert A; de Maertelaer V
    Eur Respir J; 1997 May; 10(5):1079-83. PubMed ID: 9163650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.